Corrigendum to "Analytical validation of protein biomarkers for risk of spontaneous preterm birth" [Clin. Mass Spectrom. 3 (2017) 25-38]

J Mass Spectrom Adv Clin Lab. 2022 Aug 9:25:71. doi: 10.1016/j.jmsacl.2022.07.007. eCollection 2022 Aug.

Authors

Chad Bradford¹, Rob Severinsen¹, Trina Pugmire¹, Matison Rasmussen¹, Kathryn Stoddard¹, Yuta Uemura¹, Spencer Wheelwright¹, Marija Mentinova², Daniel Chelsky², Stephen W Hunsucker³, Paul Kearney³, Durlin Hickok¹, Tracey C Fleischer¹, Ilia Ichetovkin¹, J Jay Boniface¹, Gregory C Critchfield¹, John M Peltier¹

Affiliations

¹ Sera Prognostics, Inc., 2749 East Parleys Way, Suite 200, Salt Lake City, UT 84109, USA.
² Caprion Biosciences, 201 Avenue Président Kennedy, Suite 3900, Montréal, Québec H2X 3Y7, Canada.
³ Integrated Diagnostics, Inc., 219 Terry Avenue North, Suite 110, Seattle, WA 98101, USA.

Abstract

[This corrects the article DOI: 10.1016/j.clinms.2017.06.002.].

© 2022 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.

Publication types

Published Erratum